NEOTON

This brand name is authorized in Lithuania, Poland, Romania

Active ingredients

The drug NEOTON contains one active pharmaceutical ingredient (API):

1 Phosphocreatine disodium salt
UNII 020IUV4N33 - PHOSPHOCREATINE
Read about Fosfocreatine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C01EB06 Fosfocreatine C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1009226, 1010274
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100046855
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W66298001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.